Elbasvir and grazoprevir for chronic hepatitis C genotypes 1 and 4-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Elbasvir and grazoprevir for chronic hepatitis C genotypes 1 and 4

Published:2016-09-26 Issue:11 Volume:9 Page:1413-1421
ISSN:1751-2433
Container-title:Expert Review of Clinical Pharmacology
language:en
Short-container-title:Expert Review of Clinical Pharmacology

Author:

El Kassas Mohamed¹,Elbaz Tamer²,Abd El Latif Yasmeen³,Esmat Gamal²

Affiliation:

1. Endemic Medicine Department, Faculty of Medicine, Helwan University, Cairo, Egypt

2. Endemic Hepatogastroenterology, Faculty of Medicine, Cairo University, Cairo, Egypt

3. Tropical Medicine Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/17512433.2016.1233813

Reference33 articles.

1. Grazoprevir + elbasvir for the treatment of hepatitis C virus infection

2. Global distribution and prevalence of hepatitis C virus genotypes

3. New era for management of chronic hepatitis C virus using direct antiviral agents: A review

4. Dual therapy of grazoprevir and elbasvir for the treatment of hepatitis C infection

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Structural and Synthetic Aspects of Small Ring Oxa- and Aza-Heterocyclic Ring Systems as Antiviral Activities;Viruses;2023-08-28

2. Daclatasvir as a hepatitis C infection treatment option: an up-to-date evaluation;Expert Opinion on Pharmacotherapy;2022-11-17

3. RP-HPLC Stability Indicating Method Development and Validation for Simultaneous Determination of Grazoprevir and Elbasvir;Chemistry Africa;2021-06-18

4. Treatment of hepatitis C virus infection with direct-acting antivirals plus ribavirin eliminates viral RNA from peripheral blood mononuclear cells and reduces virologic relapse in diverse hepatic parenchymal changes;Archives of Virology;2021-02-03

5. Drug–Drug Interactions of Newly Approved Direct-Acting Antiviral Agents in Patients with Hepatitis C;International Journal of General Medicine;2021-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3